Fabienne Erni is Member of the Advisory Board of BioMedInvest III LP.
Ms Erni joined Basellandschaftliche Kantonalbank in February 2016 as investment analyst for Swiss equities. Since 2017 she has led a team of four people as head of investment research. Before, she was part of the equity research team at Notenstein La Roche (former La Roche 1787), responsible for the management of the internally managed European equities fund and deputy chairperson of the investment committee. Previously she was responsible for the capital market communication of the Baloise Group as investor relations manager.
Fabienne Erni is a CFA® charterholder and graduated as a Master of Science in Business and Economics at the University of Basel.
